BioSpace News Archive

Mainz Biomed N.V. announced partnerships with Sentinel Diagnostics and Alcedis GmbH to support ColoFuture, its clinical study evaluating the potential to integrate a portfolio of novel mRNA biomarkers into ColoAlert, the Company’s highly efficacious, and easy-to-use detection test for colorectal cancer.

KeyZell has just opened a private financing round which expects to achieve 5 million euros to boost its projects and consolidate itself as one of the biotech start-ups with the greatest international projection.

NeoGenomics, Inc., a leading provider of cancer-focused genetic testing services and global oncology contract research services, announced that its liquid biopsy focused subsidiary Inivata Limited has announced the publication of new data in support of its RaDaR™ liquid biopsy test in patients with early-stage non-small cell lung cancer.

Promore Pharma AB announces that the recruitment goal has been accomplished according to plan in the company’s phase II study with the company’s drug candidate ensereptide for the prevention of skin scarring.